PROTALIX BIOTHERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.17 USD | -9.30% |
|
0.00% | -34.27% |
| 06-26 | Transcript : Protalix BioTherapeutics, Inc. - Analyst/Investor Day | |
| 05-10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 |
Chart calendar Protalix BioTherapeutics, Inc.
5c916575bc3d13f9f9cc4c5ed77.uiVu1X7wifShdnaj9wRGQ3d6MBnJFkJgZu5-l5EpwE4.41NfgxC40YTSPy_LnlQRBhxIdyuWQCwPEMMH9OsYjAvbY0OtS4X5mO1BBQ~d85675e25f09936fd43e9cc1b60c6e94
Upcoming events on Protalix BioTherapeutics, Inc.
Past events on Protalix BioTherapeutics, Inc.
| 27/06/2024 16:30 | Annual General Meeting |
| 26/06/2024 13:30 | Investor Day |
| 03/06/2024 22:30 | Bio International Convention |
| 10/05/2024 13:30 | Q1 2024 Earnings Call |
| 10/05/2024 11:50 | Q1 2024 Earnings Release |
| 14/03/2024 12:30 | Q4 2023 Earnings Call |
| 14/03/2024 10:50 | Q4 2023 Earnings Release |
| 26/02/2024 18:00 | BIO CEO & Investor Conference |
| 06/11/2023 13:30 | Q3 2023 Earnings Call |
| 06/11/2023 11:50 | Q3 2023 Earnings Release |
| 13/09/2023 20:00 | H.C. Wainwright Global Investment Conference |
| 09/08/2023 20:30 | Canaccord Genuity Growth Conference |
| 07/08/2023 13:30 | Q2 2023 Earnings Call |
| 07/08/2023 11:50 | Q2 2023 Earnings Release |
| 28/06/2023 13:30 | Annual General Meeting |
| 27/06/2023 13:00 | Investor Meeting |
| 04/05/2023 13:30 | Q1 2023 Earnings Call |
| 04/05/2023 11:50 | Q1 2023 Earnings Release |
| 27/02/2023 13:30 | Q4 2022 Earnings Call |
| 27/02/2023 11:50 | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,9 16,5 -3.61% | 16,2 35,1 -53.76% | 38,4 37,6 2.02% | 47,6 45,1 5.53% | 65,5 64,0 2.41% | 52,7 |
|
EBITDA Million USD | Released Forecast Spread | -9,10 -18,7 51.34% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,7 -20,4 47.47% | 2,71 -1,44 288.06% | -20,5 -18,5 -10.83% | -13,0 -18,2 28.44% | 10,5 11,5 -9.12% | 8,74 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,3 -28,0 34.73% | -6,52 -10,0 34.98% | -27,6 -26,0 -5.99% | -14,4 -18,8 23.43% | 8,57 9,56 -10.41% | 8,75 |
|
Net income Million USD | Released Forecast Spread | -18,3 -28,0 34.73% | -6,52 -10,0 34.98% | -27,6 -26,0 -5.99% | -14,9 -18,8 20.61% | 8,31 8,12 2.31% | 8,89 |
|
EPS USD | Released Forecast Spread | -1,23 -1,88 34.57% | -0,22 -0,34 34.33% | -0,62 -0,59 -5.08% | -0,31 -0,39 20.51% | 0,09 0,11 -14.29% | 0,12 |
| Announcement Date | 12/03/20 | 30/03/21 | 31/03/22 | 27/02/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,75 2,68 227.21% | 14,2 5,70 149.04% | 8,62 6,12 40.8% | 35,1 10,2 243.13% | 10,3 7,64 35.41% | 10,5 8,15 28.73% | 3,68 9,20 -60.03% | 12,5 | 16,3 | 20,2 | ||
|
EBIT Million USD | Released Forecast Spread | -5,52 -8,72 36.62% | -3,13 -7,38 57.67% | -2,50 -7,67 67.45% | 20,4 -1,82 1223.27% | -1,89 -3,77 49.89% | -5,62 -1,57 -257.19% | 1,73 | 4,39 | 7,48 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,33 -8,67 38.44% | -3,57 -7,33 51.36% | -3,21 -7,62 57.85% | 19,6 -2,47 896.07% | -1,72 -4,75 63.82% | -6,43 -1,87 -243.27% | 1,83 | 4,29 | 7,53 | |||
|
Net income Million USD | Released Forecast Spread | -2,29 | -5,33 -8,67 38.44% | -3,57 -7,33 51.36% | -3,74 -7,62 50.89% | -3,13 | 19,3 -2,47 883.59% | -1,85 -4,75 61.02% | -6,04 -1,87 -222.86% | 1,83 | 4,29 | 7,53 | |
|
EPS USD | Released Forecast Spread | -0,05 | -0,11 -0,18 38.89% | -0,07 -0,15 53.33% | -0,07 -0,15 53.33% | -0,05 | 0,21 -0,04 625% | -0,03 -0,07 57.14% | -0,07 -0,03 -180% | -0,06 -0,02 -200% | 0,02 | 0,06 | 0,10 |
| Announcement Date | 16/05/22 | 15/08/22 | 14/11/22 | 27/02/23 | 04/05/23 | 07/08/23 | 06/11/23 | 14/03/24 | 10/05/24 | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Protalix BioTherapeutics, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PLX Stock
- Calendar Protalix BioTherapeutics, Inc.
